Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryoport, Inc. on March 10, 2015, covering events occurring between February 20, 2015, and March 6, 2015. The filing details the entry into material definitive agreements regarding the restructuring of related-party debt and the issuance of unregistered securities to accredited investors.
Key Financial Metrics and Debt Restructuring
The filing focuses on the exchange and amendment of related party notes payable and accrued interest aggregating $1,298,004. Specific debt instruments and terms include:
- Exchange Note: Principal amount of $35,761. Accrues interest at 6% per annum. Due March 1, 2016. Convertible upon a Qualified Offering (minimum $5 million gross proceeds) at 80% of the offering price. Prepayable without penalty.
- Amended and Restated Notes: Aggregate principal amounts of $448,163.52, $266,686.21, and $208,941.36. Accrue interest at 6% per annum. Due March 1, 2016, or upon a change of control event. Convertible upon a Qualified Offering. Not prepayable without holder consent.
- Amended Original Note: Outstanding balance of $338,452.07. Accrues interest at 6% per annum commencing March 13, 2015. Due May 1, 2016. Interest payments are contingent on compliance with specific conditions, including the payment of other 2005 notes by May 1, 2016.
Warrant Issuance: In connection with these agreements, the company issued warrants to purchase shares of Common Stock at an exercise price of $0.50 per share:
- 17,880 shares (Exchange Warrant), expiring February 19, 2018.
- 448,164, 266,686, and 208,941 shares (March Warrants), expiring March 1, 2020.
- 10,000, 5,000, and 5,000 shares (March Fee Warrants) to reimburse transaction expenses, expiring March 1, 2020.
The filing does not provide revenue, profit, cash flow, or liquidity metrics for the period.
Material Changes and Unusual Items
The primary material change is the conversion of existing 2005 promissory notes into new or amended instruments with extended maturities (2016) and conversion features tied to future equity offerings. This restructuring was executed to manage debt obligations due through March 1, 2015. No discounts or commissions were paid for the issuance of the notes or warrants.
Guidance, Risks, and Contingencies
Contingencies: The conversion of the Exchange Note and Amended and Restated Notes is contingent upon the company conducting a "Qualified Offering" resulting in at least $5 million in gross cash proceeds. The interest obligation on the Amended Original Note is contingent on the company paying other 2005 notes in full by May 1, 2016.
Risks: The company faces liquidity pressure with significant principal and interest payments due in March and May 2016. Failure to secure a Qualified Offering or refinance these obligations could lead to default.
Investor Verification Checklist
- Verify the total outstanding debt balance post-restructuring and the specific maturity dates (March 1, 2016, and May 1, 2016).
- Confirm the company's progress toward a "Qualified Offering" to trigger note conversion and avoid cash repayment.
- Review the full text of Exhibits 4.1 through 10.5 for detailed covenants and default provisions.
- Assess the dilution impact of the approximately 956,000 warrants issued at a $0.50 exercise price.
- Check subsequent filings for updates on the repayment of the 2005 notes required to waive interest on the Amended Original Note.